(lp0
S"Incyte Corporation at the Cowen Healthcare Conference: 4 Things You'll Want to ... Motley Fool - Mar 9, 2017 Few biotechs have enjoyed as fun a ride as Incyte Corporation  in recent years. The stock has soared more than 700% since early 2012 thanks primarily to tremendous success for cancer drug Jakafi.Earnings Clues on Incyte Corporation , Mastercard Incorporated (MA ... - StockNewsJournal"
p1
aS"Incyte Corporation Stock Rises on Price Target Increase TheStreet.com - Mar 13, 2017 Incyte  shares were up 1.3% to $151.21 in premarket trading Monday after analysts at Credit Suisse raised the company's price target to $174 from $136.Gilead Looking To Buy Incyte? It Makes Sense - BenzingaWhy Investors remained confident on Realty Income Corporation , Incyte ... - StockNewsJournal"
p2
aS"Buy or Sell? What Analysts Recommends: Baker Hughes Incorporated , Incyte ... StockNewsJournal - Mar 27, 2017 Incyte Corporation , maintained return on investment for the last twelve months at 9.46, higher than what Reuters data shows regarding industry's average."
p3
aS'Growth Report on Incyte Corporation  Aiken Advocate - 10 hours ago Wall Street sell-side analysts are projecting Incyte Corporation  to grow at an accelerated rate over the next 5 years.Institutional Investors Remain the Majority Holders of Company Stock: Incyte ... - Midway MonitorNext Weeks Broker Price Targets For Incyte Corporation  - Fiscal Standard'
p4
aS"Why Incyte Corporation  Shares Are Skyrocketing Simply Wall St - Mar 12, 2017 Including an 8% jump on Friday, Incyte Corporation  shares are up a staggering 110% over the past year. The Delaware-based biotech firm is experiencing a growing demand for its cancer drug Jakafi (to treat myelofibrosis and polycythemia&nbsp;...Incyte Corporation  Moves Higher on Volume Spike for March 10 - Equities.comReliable stocks in today's share market: Incyte Corporation  - The News Journal"
p5
aS'Calithera to Receive $12 Million Milestone Payment From Incyte for Achievement ... GlobeNewswire  - 20 hours ago ... against tumor metabolism and tumor immunology targets for the treatment of cancer, announced today that it has achieved pharmacokinetic and pharmacodynamic goals for CB-1158 which, under its agreement with Incyte Corporation, entitles the Company&nbsp;...Calithera Biosciences  Hits Milestone with Incyte Corp  Partnership - Economic Calendar'
p6
aS"Sell-Side Analyst's Predictions: ARRIS International plc , Incyte ... The USA Commerce - Mar 27, 2017 Shares of ARRIS International plc  dropped -0.19% to $26.62. During the trading on 03/24/2017, Company's stock ranged from $26.95 to $26.42."
p7
aS'Penn cancer center forms research partnership with Incyte pharmaceutical company The Daily Pennsylvanian - Mar 2, 2017 Incyte Corporation, a pharmaceutical company, is entering into a multi-year research partnership with the Abramson Cancer Center at Penn.'
p8
aS"What's Happening To These Stocks?  Incyte Corporation , Microchip ... Post Analyst - 16 hours ago Incyte Corporation  failed to surprise the stock market in its last reported earnings when it earned $0.05 a piece versus the consensus-estimated $0.13."
p9
aS"Drilling Down Into Incyte Corporation  StockNewsJournal - Mar 23, 2017 Incyte Corporation  is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $141.28, up from yesterday's close by 0.39%."
p10
a.